STD検査市場：タイプ別、製品タイプ別、検査設定別、適応症別、エンドユーザー別-2024-2030年の世界予測

STD検査市場規模は2023年に94億4,000万米ドルと推定され、2024年には99億7,000万米ドルに達し、CAGR 5.90％で2030年には141億1,000万米ドルに達すると予測されます。

性感染症（STD）検査市場は、性感染症（STI）の存在を特定するために使用される様々な医療検査で構成されます。STD検査は、個人の健康を確保し、STDの蔓延を防ぎ、タイムリーな治療を促進する上で重要な役割を果たしています。STD検査の必要性は、症状が明らかになった時や、多くのSTDが長期間無症状のままであることを考慮した予防的な健康対策として生じます。検査の種類は血液検査、尿検査、綿棒検査、身体検査など多岐にわたり、それぞれHIV、ヘルペス、クラミジア、淋病、梅毒、ヒトパピローマウイルス（HPV）など特定の感染症を対象としています。STD検査市場に影響を与える重要な成長要因としては、一般住民のSTDに対する意識の高まり、STDの蔓延と闘うための政府・非政府の取り組み、診断技術の進歩などが挙げられます。精度の向上、アクセシビリティの向上、STD検査にまつわるスティグマの低下が、市場の成長をさらに後押ししています。さらに、世界の性病罹患率の上昇により、効果的かつ効率的な検査ソリューションに対する継続的な需要が必要とされています。しかし、市場は、特に保守的で発展が遅れている地域における社会的偏見、経済的制約、限られた医療インフラ、認識不足などの課題に直面しています。STD検査市場では、デジタルヘルスプラットフォームとSTD検査サービスの統合による新たなビジネス機会が生まれつつあり、個人向けに控えめで便利な遠隔ソリューションを提供しています。1つのサンプルから複数の性病を検出できる、より包括的なマルチプレックス検査パネルの開発と商品化は、大きな成長機会をもたらします。さらに、公衆衛生への取り組みや教育キャンペーンと相まって、STD罹患率の高い未開拓地域への拡大は、STD検査市場に新たな道を開く可能性があります。

タイプ：非侵襲的であることから、スワブ検査への嗜好が高まるSTD検査

スワブ検査は、クラミジア、淋病、ヒトパピローマウイルス（HPV）、ヘルペスなどの性病の診断に不可欠です。これらの検査は非侵襲的で、尿道、膣、子宮頸部、咽頭などの感染部位から直接サンプルを採取できるため、好まれています。血液検査は、B型とC型肝炎、梅毒、HIV、単純ヘルペスウイルスの診断に用いられます。血液検査は、STDが血流に入ったと疑われる場合や、抗体や病原体そのもの存在を確認するために行われます。腰椎穿刺は、梅毒や単純ヘルペスウイルスによる神経系感染の診断に極めて重要です。脳脊髄液を採取し、STD病原体の存在を検出します。この検査は複雑なため、経験豊富な医療専門家の指導のもと、病院で行われます。尿検査はクラミジアや淋病の診断によく用いられます。検体採取が容易で非侵襲的であるため、特に大規模なスクリーニング・プログラムや自己管理検査に適しています。疑われるSTD、感染部位、患者の快適さが、STD検査の検査法の選択に影響します。血液検査や腰椎穿刺は侵襲性が高いが、全身性の感染症や神経系に影響を及ぼす感染症の検出には必要です。部位特異的な診断が可能な綿棒検査や、手軽さと利便性で知られる尿検査は、クラミジアや淋病を含む感染症のスクリーニングに適しています。

製品タイプ：大量検査環境におけるハイスループット機器の必要性

STD検査に含まれる機器は、STDの原因となる病原体の検出や分析に使用される機器です。PCR装置、ELISAリーダー、質量分析計などが含まれます。検査機器は、大規模で精度の高い検査を実施するための検査室に不可欠なものです。大規模な医療施設や大量の検査を行う検査室では、機器が好まれます。初期費用は高くなるが、機器は耐久性とスループット能力により、大規模な業務においてより高い効率性と長期的な検査単価の低減を実現します。試薬とキットは、検査の種類に応じて、機器と組み合わせて、または単独で、STD検査のために明確に使用される化学的または生物学的成分です。綿棒、化学試薬、コントロール・サンプルなど、検査手順に必要なすべてのものが含まれます。試薬とキットは、大規模ラボから小規模クリニック、在宅検査サービスまで、様々な医療プロバイダーに支持されています。検査量に柔軟性があり、特定の検査に必要な機器に多額の投資を必要としないです。これらは、対象を絞った検査や、大規模な検査機器へのアクセスが制限されている場合に理想的です。

検査設定：利便性とスピードでPOC検査が人気

性病の検査室検査では、個人からサンプル（血液、尿、綿棒）を採取し、分析のためにこれらのサンプルを専門の検査室に送る。この方法は正確で、HIV、梅毒、クラミジア、淋病など数種類のSTDを検査できることで知られています。検査室での検査は、特に無症候性感染や複数の性病が疑われる場合など、総合的な検査が必要な場合に好まれます。検査室検査は、POC検査で陽性となった後の確認検査に選択されます。ポイントオブケア（POC）検査は、医師の診察室やクリニック、あるいは自己検査キットを用いて自宅でなど、患者の診療時間や場所で実施されます。この方法では迅速な結果が得られるため、即座に治療を決定するために極めて重要です。POC検査は、迅速な結果が必要な場合や、検査施設へのアクセスが困難な場合に適しています。POC検査は、高リスク集団や、患者が検査結果を受け取り、その後の治療を受けられる可能性を高めるために、特に有用です。

適応症：増加するクラミジアの発生と高度な検査技術の必要性

クラミジアは非常に一般的な細菌感染症であり、多くの場合、ほとんど、あるいは全く症状を示さないです。25歳以下の性的に活発な人や、新しいパートナーがいる人、複数のパートナーがいる人には特に検査が推奨されます。検査室ベースの核酸増幅検査（NAAT）が望ましい検出方法です。主にHSV-2によって引き起こされる性器ヘルペスは、ウイルス培養検査、PCR検査、抗体の血液検査によって診断されます。ウイルスを直接検出するPCR検査が正確であるため、好まれています。淋菌の検査は、抗生物質耐性菌が増加しているため非常に重要です。クラミジアに加え、NAATは淋病検出のゴールドスタンダードとなっています。肝臓を侵すウイルス感染症であるB型肝炎のスクリーニングでは、血液検査でHBV DNAレベル、表面抗原、抗体を検出します。HIV検査は、病気の早期発見と管理に不可欠です。検査は迅速抗体検査から抗原抗体複合検査、核酸検査（NAT）まで多岐にわたる。ヒトパピローマウイルス（HPV）は最も一般的な性感染症で、特定の株は子宮頸がんの原因となります。検査は主に女性を対象とし、高リスクのHPV DNA型を検出します。梅毒検査では通常、最初に非トレポネム抗体検査を行い、その後トレポネム抗体検査で確認します。従来のRPR（Rapid Plasma Reagin）検査は、新しいEIA（Enzyme Immunoassays）とともに広く使用されています。

エンドユーザー：診断センターでのSTD検査の使用拡大による短納期化

診断センターは、性感染症（STD）を含む様々な健康状態の検出と分析を専門としています。総合的な検診を必要とする患者や守秘義務を求める患者に対応しています。このセグメントの需要は、アクセスのしやすさ、迅速な検査時間、高度な検査技術の利用可能性によって牽引されています。患者は、定期的なスクリーニングや匿名性を求める場合に診断センターを好みます。これらのセンターは最新の診断ツールを備えており、カウンセリングや即時分析を提供する専門家がいます。病院での治療を必要としない患者には特に好まれています。病院やクリニックは、STD検査を含む様々な医療サービスを提供しています。性病の診断、治療、フォローアップを含む包括的な医療を求める個人にとって、これらの病院やクリニックは不可欠です。このセグメントは、医療における不可欠な役割により、大きな市場シェアを獲得しています。性病の症状を持つ患者や検査と並行して診察を必要とする患者は、病院やクリニックを好みます。これらの施設は、患者が一箇所で診断と治療の両方を受けられる統合医療という利点があります。これらの施設は、専門的な診察が必要な重症または複雑なSTD症例に対応するために不可欠です。診断センターは、タイムリーで多くの場合より手頃な価格の検査サービスを提供するために合理化されています。診断センターでは専門的な治療が提供されるため、病院で受けられるような包括的な医療サポートが必要になる場合があります。病院やクリニックは包括的なケアを提供する一方で、検査の所要時間という点では診断センターに及ばない可能性があります。しかし、専門医による治療やカウンセリングなど、きめ細かな患者ケアを提供する点では勝っています。

地域別洞察

南北アメリカ、特に米国とカナダは、イノベーションとアクセシビリティを重視する先進市場です。米国では、消費者の認知度が高く、研究開発をリードする大手企業が存在することが市場の特徴です。最近の特許では、非侵襲的な検査法と迅速な結果が強調されています。カナダ市場は、利用しやすい医療を優先しており、公衆衛生キャンペーンや検査センターへの多額の投資により、STDへの認識と予防を高めています。南米のSTD検査市場は堅調に推移しており、中でもブラジルはSTD有病率の上昇により潜在力を秘めており、政府が公衆衛生キャンペーンに注力し、医療施設の改善が市場拡大に寄与しています。欧州、中東、アフリカ地域は、STD検査市場において多様な様相を呈しています。欧州連合（EU）諸国は、確立された医療システムと継続的な研究イニシアチブにより、高度な診断検査に対する高い需要を示しています。同地域では、革新的な検査ソリューションを開発するための官民パートナーシップが拡大しています。対照的に中東では、教育キャンペーンやインフラへの投資により、一般市民の意識を高め、STD検査に対する文化的障壁を取り除くことに注力しています。アフリカは、資源の制約による独自の課題に直面する一方で、国際的な援助やニーズに合わせた革新的な検査ソリューションの増加を目の当たりにしており、手頃な価格で利用しやすいSTD検査の市場が拡大していることを示しています。アジア太平洋はSTD検査市場の急速な開拓を経験しており、急速に拡大する医療インフラ、中間層の人口増加、公衆衛生に向けた政府の取り組み強化がその原動力となっています。中国、インド、オーストラリアなどの国々は、啓発キャンペーンに注力し、診断検査に先進技術を導入することで、この成長を促進しています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスはSTD検査市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を記載しています。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます。フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、STD検査市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、このセグメントの競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています。

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を記載しています。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発とイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を記載しています。

本レポートは、以下のような主要な質問に対応しています。

1.STD検査市場の市場規模と予測は？

2.STD検査市場の予測期間中に投資を検討すべき製品、セグメント、用途、セグメントは何か？

3.STD検査市場の技術動向と規制枠組みは？

4.STD検査市場における主要ベンダーの市場シェアは？

5.STD検査市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で性感染症の発生率と蔓延が増加
    • 教育キャンペーンを通じて性感染症に関する意識を高める
  • 抑制要因
    • STD検査製品の承認に関する厳格な規制ガイドラインに関する問題
  • 機会
    • 性感染症診断における継続的な技術的進歩
    • 全国規模のスクリーニング検査の実施を増やし、STD検査の採用を促進する
  • 課題
    • 専門医の診察を受けることに伴う社会的偏見
• 市場セグメンテーション分析
  • タイプ：STD検査のスワブ検査は非侵襲性のため好まれる傾向が高まっている
  • 製品タイプ：大量検査環境向けの高スループット機器の必要性
  • 検査設定：比類のない利便性とスピードを誇るPOC検査を優先
  • 適応症：クラミジアの発生率増加と高度な検査技術の必要性
  • エンドユーザー：診断センターでのSTD検査の使用を拡大し、ターンアラウンド時間を短縮
• 市場動向分析
  • 自宅でできるSTD検査キットの人気が高まり、南北アメリカ地域全体で大手企業が強力な足場を築いている
  • アジア太平洋における性感染症の蔓延により、性感染症に対する政府の啓発活動を拡大
  • 欧州、中東、アフリカ地域全体でSTD検査へのアクセスを容易にするための診断ソリューションと革新的な製品提供に関する厳格な規制枠組み
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析

第6章 STD検査市場：タイプ別

• イントロダクション
• 血液検査
• 腰椎穿刺
• スワブ検査
• 尿検査

第7章 STD検査市場：製品タイプ別

• イントロダクション
• 機器
• 試薬とキット

第8章 STD検査市場：検査設定別

• イントロダクション
• 研究室
• ポイントオブケア

第9章 STD検査市場：適応症別

• イントロダクション
• クラミジア
• 性器ヘルペス
• 淋病
• B型肝炎
• HIV/エイズ
• ヒトパピローマウイルス
• 梅毒

第10章 STD検査市場：エンドユーザー別

• イントロダクション
• 診断センター
• 病院・クリニック

第11章 南北アメリカのSTD検査市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋のSTD検査市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカのSTD検査市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析

第15章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. STD TESTING MARKET RESEARCH PROCESS
• FIGURE 2. STD TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL STD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL STD TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL STD TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. STD TESTING MARKET DYNAMICS
• FIGURE 7. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 14. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 16. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 20. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 22. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 25. STD TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 26. STD TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. STD TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL STD TESTING MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL STD TESTING MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL STD TESTING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL STD TESTING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL STD TESTING MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL STD TESTING MARKET SIZE, BY BLOOD TESTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL STD TESTING MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL STD TESTING MARKET SIZE, BY LUMBAR PUNCTURE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL STD TESTING MARKET SIZE, BY SWAB TESTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL STD TESTING MARKET SIZE, BY SWAB TESTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL STD TESTING MARKET SIZE, BY URINE TESTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL STD TESTING MARKET SIZE, BY URINE TESTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL STD TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL STD TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL STD TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL STD TESTING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL STD TESTING MARKET SIZE, BY LABORATORY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL STD TESTING MARKET SIZE, BY LABORATORY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL STD TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL STD TESTING MARKET SIZE, BY POINT OF CARE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL STD TESTING MARKET SIZE, BY CHLAMYDIA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL STD TESTING MARKET SIZE, BY CHLAMYDIA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL STD TESTING MARKET SIZE, BY GENITAL HERPES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL STD TESTING MARKET SIZE, BY GENITAL HERPES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL STD TESTING MARKET SIZE, BY GONORRHEA, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL STD TESTING MARKET SIZE, BY GONORRHEA, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL STD TESTING MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL STD TESTING MARKET SIZE, BY HEPATITIS B, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL STD TESTING MARKET SIZE, BY HIV/AIDS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL STD TESTING MARKET SIZE, BY HIV/AIDS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL STD TESTING MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL STD TESTING MARKET SIZE, BY HUMAN PAPILLOMAVIRUS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL STD TESTING MARKET SIZE, BY SYPHILIS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL STD TESTING MARKET SIZE, BY SYPHILIS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL STD TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL STD TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL STD TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL STD TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. AMERICAS STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 52. AMERICAS STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 53. AMERICAS STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 54. AMERICAS STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 55. AMERICAS STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 56. AMERICAS STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 57. AMERICAS STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 58. AMERICAS STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 59. AMERICAS STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 60. AMERICAS STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 61. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 62. AMERICAS STD TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 63. ARGENTINA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 64. ARGENTINA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 65. ARGENTINA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 66. ARGENTINA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 67. ARGENTINA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 68. ARGENTINA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 69. ARGENTINA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 70. ARGENTINA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 71. ARGENTINA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 72. ARGENTINA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 73. BRAZIL STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 74. BRAZIL STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 75. BRAZIL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 76. BRAZIL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 77. BRAZIL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 78. BRAZIL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 79. BRAZIL STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 80. BRAZIL STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 81. BRAZIL STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 82. BRAZIL STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 83. CANADA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 84. CANADA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 85. CANADA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 86. CANADA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 87. CANADA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 88. CANADA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 89. CANADA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 90. CANADA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 91. CANADA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 92. CANADA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 93. MEXICO STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 94. MEXICO STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 95. MEXICO STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 96. MEXICO STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 97. MEXICO STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 98. MEXICO STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 99. MEXICO STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 100. MEXICO STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 101. MEXICO STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 102. MEXICO STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 103. UNITED STATES STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 104. UNITED STATES STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 105. UNITED STATES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 106. UNITED STATES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 107. UNITED STATES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 108. UNITED STATES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 109. UNITED STATES STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 110. UNITED STATES STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 111. UNITED STATES STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 112. UNITED STATES STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 113. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 114. UNITED STATES STD TESTING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 115. ASIA-PACIFIC STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 116. ASIA-PACIFIC STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 117. ASIA-PACIFIC STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 118. ASIA-PACIFIC STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 119. ASIA-PACIFIC STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 120. ASIA-PACIFIC STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 121. ASIA-PACIFIC STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 122. ASIA-PACIFIC STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 123. ASIA-PACIFIC STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 124. ASIA-PACIFIC STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 125. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 126. ASIA-PACIFIC STD TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 127. AUSTRALIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 128. AUSTRALIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 129. AUSTRALIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 130. AUSTRALIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 131. AUSTRALIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 132. AUSTRALIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 133. AUSTRALIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 134. AUSTRALIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 135. AUSTRALIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 136. AUSTRALIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 137. CHINA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 138. CHINA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 139. CHINA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 140. CHINA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 141. CHINA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 142. CHINA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 143. CHINA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 144. CHINA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 145. CHINA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 146. CHINA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 147. INDIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 148. INDIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 149. INDIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 150. INDIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 151. INDIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 152. INDIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 153. INDIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 154. INDIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 155. INDIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 156. INDIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 157. INDONESIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 158. INDONESIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 159. INDONESIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 160. INDONESIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 161. INDONESIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 162. INDONESIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 163. INDONESIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 164. INDONESIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 165. INDONESIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 166. INDONESIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 167. JAPAN STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 168. JAPAN STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 169. JAPAN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 170. JAPAN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 171. JAPAN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 172. JAPAN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 173. JAPAN STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 174. JAPAN STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 175. JAPAN STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 176. JAPAN STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 177. MALAYSIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 178. MALAYSIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 179. MALAYSIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 180. MALAYSIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 181. MALAYSIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 182. MALAYSIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 183. MALAYSIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 184. MALAYSIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 185. MALAYSIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 186. MALAYSIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 187. PHILIPPINES STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 188. PHILIPPINES STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 189. PHILIPPINES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 190. PHILIPPINES STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 191. PHILIPPINES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 192. PHILIPPINES STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 193. PHILIPPINES STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 194. PHILIPPINES STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 195. PHILIPPINES STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 196. PHILIPPINES STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 197. SINGAPORE STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 198. SINGAPORE STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 199. SINGAPORE STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 200. SINGAPORE STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 201. SINGAPORE STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 202. SINGAPORE STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 203. SINGAPORE STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 204. SINGAPORE STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 205. SINGAPORE STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 206. SINGAPORE STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 207. SOUTH KOREA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 208. SOUTH KOREA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 209. SOUTH KOREA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 210. SOUTH KOREA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 211. SOUTH KOREA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 212. SOUTH KOREA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 213. SOUTH KOREA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 214. SOUTH KOREA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 215. SOUTH KOREA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 216. SOUTH KOREA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 217. TAIWAN STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 218. TAIWAN STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 219. TAIWAN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 220. TAIWAN STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 221. TAIWAN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 222. TAIWAN STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 223. TAIWAN STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 224. TAIWAN STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 225. TAIWAN STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 226. TAIWAN STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 227. THAILAND STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 228. THAILAND STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 229. THAILAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 230. THAILAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 231. THAILAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 232. THAILAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 233. THAILAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 234. THAILAND STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 235. THAILAND STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 236. THAILAND STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 237. VIETNAM STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 238. VIETNAM STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 239. VIETNAM STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 240. VIETNAM STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 241. VIETNAM STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 242. VIETNAM STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 243. VIETNAM STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 244. VIETNAM STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 245. VIETNAM STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 246. VIETNAM STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 247. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 248. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 249. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 250. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 251. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 252. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 253. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 254. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 255. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 256. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 257. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 258. EUROPE, MIDDLE EAST & AFRICA STD TESTING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 259. DENMARK STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 260. DENMARK STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 261. DENMARK STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 262. DENMARK STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 263. DENMARK STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 264. DENMARK STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 265. DENMARK STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 266. DENMARK STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 267. DENMARK STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 268. DENMARK STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 269. EGYPT STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 270. EGYPT STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 271. EGYPT STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 272. EGYPT STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 273. EGYPT STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 274. EGYPT STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 275. EGYPT STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 276. EGYPT STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 277. EGYPT STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 278. EGYPT STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 279. FINLAND STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 280. FINLAND STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 281. FINLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 282. FINLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 283. FINLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 284. FINLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 285. FINLAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 286. FINLAND STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 287. FINLAND STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 288. FINLAND STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 289. FRANCE STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 290. FRANCE STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 291. FRANCE STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 292. FRANCE STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 293. FRANCE STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 294. FRANCE STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 295. FRANCE STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 296. FRANCE STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 297. FRANCE STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 298. FRANCE STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 299. GERMANY STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 300. GERMANY STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 301. GERMANY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 302. GERMANY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 303. GERMANY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 304. GERMANY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 305. GERMANY STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 306. GERMANY STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 307. GERMANY STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 308. GERMANY STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 309. ISRAEL STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 310. ISRAEL STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 311. ISRAEL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 312. ISRAEL STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 313. ISRAEL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 314. ISRAEL STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 315. ISRAEL STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 316. ISRAEL STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 317. ISRAEL STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 318. ISRAEL STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 319. ITALY STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 320. ITALY STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 321. ITALY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 322. ITALY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 323. ITALY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 324. ITALY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 325. ITALY STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 326. ITALY STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 327. ITALY STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 328. ITALY STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 329. NETHERLANDS STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 330. NETHERLANDS STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 331. NETHERLANDS STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 332. NETHERLANDS STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 333. NETHERLANDS STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 334. NETHERLANDS STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 335. NETHERLANDS STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 336. NETHERLANDS STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 337. NETHERLANDS STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 338. NETHERLANDS STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 339. NIGERIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 340. NIGERIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 341. NIGERIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 342. NIGERIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 343. NIGERIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 344. NIGERIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 345. NIGERIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 346. NIGERIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 347. NIGERIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 348. NIGERIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 349. NORWAY STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 350. NORWAY STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 351. NORWAY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 352. NORWAY STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 353. NORWAY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 354. NORWAY STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 355. NORWAY STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 356. NORWAY STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 357. NORWAY STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 358. NORWAY STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 359. POLAND STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 360. POLAND STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 361. POLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 362. POLAND STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 363. POLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 364. POLAND STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 365. POLAND STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 366. POLAND STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 367. POLAND STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 368. POLAND STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 369. QATAR STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 370. QATAR STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 371. QATAR STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 372. QATAR STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 373. QATAR STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 374. QATAR STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 375. QATAR STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 376. QATAR STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 377. QATAR STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 378. QATAR STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 379. RUSSIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 380. RUSSIA STD TESTING MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 381. RUSSIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
• TABLE 382. RUSSIA STD TESTING MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
• TABLE 383. RUSSIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2018-2023 (USD MILLION)
• TABLE 384. RUSSIA STD TESTING MARKET SIZE, BY TEST SETTINGS, 2024-2030 (USD MILLION)
• TABLE 385. RUSSIA STD TESTING MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
• TABLE 386. RUSSIA STD TESTING MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
• TABLE 387. RUSSIA STD TESTING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
• TABLE 388. RUSSIA STD TESTING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
• TABLE 389. SAUDI ARABIA STD TESTING MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 390. SAUDI ARABIA STD

[195 Pages Report] The STD Testing Market size was estimated at USD 9.44 billion in 2023 and expected to reach USD 9.97 billion in 2024, at a CAGR 5.90% to reach USD 14.11 billion by 2030.

Sexually transmitted disease (STD) testing market comprises various medical examinations used to identify the presence of sexually transmitted infections (STIs). STD testing plays a critical role in ensuring individual health, preventing the spread of STDs, and facilitating timely treatment. The need for STD testing arises when symptoms are apparent and as a preventive health measure, considering that many STDs may remain asymptomatic for prolonged periods. The types of tests conducted vary widely, encompassing blood tests, urine tests, swabs, and physical examinations, each targeting specific infections such as HIV, herpes, chlamydia, gonorrhea, syphilis, and human papillomavirus (HPV). The significant growth factors impacting the STD testing market include increasing awareness about STDs among the general population, governmental and non-governmental efforts to combat the spread of STDs, and advancements in diagnostic technologies. Enhanced accuracy, accessibility, and the declining stigma associated with STD testing have further propelled the market's growth. Additionally, the rising incidence rates of STDs globally necessitate continuous demand for effective and efficient testing solutions. However, the market faces challenges, including social stigma, particularly in conservative and less-developed regions, financial constraints, limited healthcare infrastructure, and lack of awareness. New opportunities in the STD testing market are emerging from integrating digital health platforms with STD testing services, which offer discreet, convenient, and remote solutions for individuals. The development and commercialization of more comprehensive multiplex testing panels, capable of detecting multiple STDs from a single sample, present significant growth venues. Moreover, expanding into underserved regions with high STD prevalence, coupled with public health initiatives and education campaigns, can open new avenues for the STD testing market.

Type: Increasing preference for swab tests for STD testing for their non-invasive nature

Swab tests are essential for diagnosing STDs such as chlamydia, gonorrhea, human papillomavirus (HPV), and herpes. These tests are preferred for their non-invasive nature and the ability to collect samples directly from the site of infection, such as the urethra, vagina, cervix, or throat. Blood tests are used to diagnose hepatitis B and C, syphilis, HIV, and herpes simplex virus. They are preferred when an STD is suspected to have entered the bloodstream or to check for the presence of antibodies or the pathogen itself. Lumbar puncture is crucial for diagnosing nervous system infections caused by syphilis or herpes simplex virus. It involves collecting cerebrospinal fluid to detect the presence of the STD pathogen. This procedure is conducted in hospital settings under the guidance of experienced medical professionals due to its complexity. Urine tests are frequently used for diagnosing chlamydia and gonorrhea. They are favored for their ease of sample collection and non-invasive nature, making them especially suitable for large-scale screening programs or self-administered testing. The suspected STD, the site of infection, and patient comfort influence the choice of STD testing method. Blood tests and lumbar punctures are more invasive but necessary for detecting systemic infections and those affecting the nervous system. Swab tests, offering site-specific diagnosis, and urine tests, known for their ease and convenience, are more suited for widespread screening of infections, including chlamydia and gonorrhea.

Product Type: Need for high-throughput instruments for high-volume testing environments

Instruments in STD testing are devices used for the detection and analysis of pathogens responsible for STDs. These include PCR machines, ELISA readers, and mass spectrometers. Instruments are integral in laboratories for conducting large-scale and highly accurate tests. Instruments are preferred by larger health facilities and laboratories that perform high volumes of tests. The upfront cost is higher, while instruments offer greater efficiency and lower long-term costs per test for large-scale operations due to their durability and throughput capabilities. Reagents and kits are chemical or biological components used explicitly for STD testing in conjunction with instruments or standalone, depending on the test type. These include everything necessary for the testing procedure, such as swabs, chemical reagents, and control samples. Reagents and kits are favored by varied healthcare providers, from large laboratories to smaller clinics and at-home testing services. They offer flexibility in testing volume, with no significant investment required in instrumentation for certain tests. These are ideal for targeted testing and situations where access to large laboratory instruments is limited.

Test Settings: Preference for POC tests for their unmatched convenience and speed

Laboratory testing for STDs involves collecting samples (blood, urine, or swabs) from individuals and sending these samples to a specialized laboratory for analysis. This method is known for its accuracy and the ability to test for several types of STDs, including HIV, syphilis, chlamydia, gonorrhea, and others. Laboratory testing is preferred when comprehensive testing is required, especially for asymptomatic infections or when multiple STDs are suspected. It is chosen for confirmatory testing following a positive POC test. Point-of-care (POC) testing is conducted at the time and place of patient care, such as in a doctor's office, a clinic, or even at home with self-testing kits. This method provides rapid results, which is crucial for immediate treatment decisions. POC testing is preferred in settings where rapid results are necessary or when access to laboratory facilities is unavailable. It is particularly useful for high-risk populations and to increase the chance of patients receiving their results and subsequent treatment.

Indication: Rising occurrence of chlamydia and need for sophisticated testing technologies

Chlamydia is a highly common bacterial infection that often presents with few or no symptoms. Testing is particularly recommended for sexually active individuals under 25 and those with new or multiple partners. Laboratory-based nucleic acid amplification tests (NAATs) are the preferred method for detection. Genital Herpes, primarily caused by HSV-2, is diagnosed through viral culture tests, PCR tests, and blood tests for antibodies. The preference leans towards PCR testing for its accuracy in detecting the virus directly. Gonorrhea testing is crucial due to the bacteria's growing antibiotic resistance. In addition to Chlamydia, NAATs serve as the gold standard for gonorrhea detection. For Hepatitis B, a viral infection affecting the liver, screening involves blood tests to detect HBV DNA levels, surface antigens, and antibodies. HIV testing is critical for early detection and management of the disease. Tests range from rapid antibody tests to combined antigen/antibody tests and nucleic acid tests (NATs). Human papillomavirus (HPV) is the most common sexually transmitted infection, with certain strains causing cervical cancer. Testing mainly targets women and involves detecting high-risk HPV DNA types. Syphilis testing typically involves initial non-treponemal antibody testing followed by confirmatory treponemal antibody tests. Traditional RPR (Rapid Plasma Reagin) tests are widely used with newer EIA (Enzyme Immunoassays).

End-user: Expanding usage of STD testing at diagnostic centers for quick turnaround time

Diagnostic centers specialize in the detection and analysis of various health conditions, including sexually transmitted diseases (STDs). They cater to patients requiring comprehensive screening and those who seek confidentiality. The demand in this segment is driven by their accessibility, quick turnaround time, and the availability of advanced testing technologies. Patients prefer diagnostic centers for routine screenings or when seeking anonymity. These centers are provided with the latest diagnostic tools and have specialists to offer counseling and immediate analysis. They are particularly favored by individuals not requiring hospital-based interventions. Hospitals and clinics provide various medical services, including STD testing. They are essential for individuals seeking comprehensive medical care, including diagnosis, treatment, and follow-up for STDs. This segment captures a significant market share due to its integral role in health care. Patients with symptoms of STDs or those in need of consultation alongside testing prefer hospitals and clinics. These facilities offer the advantage of integrated care, where patients can receive both diagnosis and treatment in one location. They are vital for handling more severe or complex STD cases that require specialized medical attention. Diagnostic centers are streamlined for timely and often more affordable testing services. They offer specialized care and may need more comprehensive medical support, which is available in hospitals. While hospitals and clinics provide comprehensive care, they may not match the diagnostic centers in terms of testing turnaround times. However, they prevail in offering detailed patient care, including treatment and counseling by specialists.

Regional Insights

The Americas, particularly the United States and Canada, represent a developed market with a strong emphasis on innovation and accessibility. In the United States, the market is defined by high consumer awareness and the presence of major companies leading research and development. Recent patents emphasize non-invasive testing methods and rapid results. Canada's market prioritizes accessible healthcare, with significant investments in public health campaigns and testing centers to increase STD awareness and prevention. The STD testing market in South America is progressing steadily, with Brazil carrying potential due to rising STD prevalence, governmental focus on public health campaigns, and improving healthcare facilities are instrumental in the market's expansion. The EMEA region presents a diverse landscape in the STD testing market. European Union countries exhibit a high demand for advanced diagnostic tests, driven by well-established healthcare systems and ongoing research initiatives. The region has witnessed growth in public-private partnerships for developing innovative testing solutions. In contrast, the Middle East focuses on increasing public awareness and breaking cultural barriers to STD testing with investments in educational campaigns and infrastructure. Africa faces unique challenges due to resource constraints while witnessing a rise in international aid and innovative testing solutions tailored to its needs, indicating a growing market for affordable and accessible STD testing. The APAC region is experiencing rapid development in the STD testing market, driven by rapidly expanding healthcare infrastructure, a growing middle-class population, and increased government initiatives toward public health. Countries such as China, India, and Australia are promoting this growth, focusing on awareness campaigns and integrating advanced technologies for diagnostic testing.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the STD Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the STD Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the STD Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accuquik by AdvaCare Pharma, Alpine Biomedicals Pvt. Ltd., ARCpoint Labs, Becton, Dickinson and Company, Bio Lab Diagnostics (I) Private Limited, Bio-Rad Laboratories, Inc., bioMerieux SA, BioReference Health, LLC by OPKO HEALTH, INC., Danaher Corporation, Daye Limited, Everlywell, Inc., F. Hoffmann-La Roche Ltd., Getein Biotech, Inc., Grifols, S.A., Hologic, Inc., JAL Medical by OK Biotech Co. Ltd., Laboratory Corporation of America Holdings, LifeCell, Lorne Laboratories Limited by Calibre Scientific, Meridian Bioscience Inc. by SD Biosensor, Inc., OraSure Technologies, Inc., Personalabs, Qiagen N.V., Quest Diagnostics, Inc., Randox Laboratories Ltd., Seegene Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Viatris Inc., and Wondfo Biotech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the STD Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • Blood Tests
  • Lumbar Puncture
  • Swab Tests
  • Urine Tests

• Product Type
  • Instruments
  • Reagents & Kits

• Test Settings
  • Laboratory
  • Point of Care

• Indication
  • Chlamydia
  • Genital Herpes
  • Gonorrhea
  • Hepatitis B
  • HIV/AIDS
  • Human Papillomavirus
  • Syphilis

• End-user
  • Diagnostic Centers
  • Hospitals & Clinics

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the STD Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the STD Testing Market?

3. What are the technology trends and regulatory frameworks in the STD Testing Market?

4. What is the market share of the leading vendors in the STD Testing Market?

5. Which modes and strategic moves are suitable for entering the STD Testing Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence and prevalence of sexually transmitted diseases worldwide
    • 5.1.1.2. Increasing awareness about STDs through education campaigns
  • 5.1.2. Restraints
    • 5.1.2.1. Issues regarding strict regulatory guidelines for approval of STD testing products
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing technical advancements in STD disease diagnostics
    • 5.1.3.2. Increasing implementation of nationwide screening tests to encourage the adoption of STD testing
  • 5.1.4. Challenges
    • 5.1.4.1. Social stigma associated with visiting specialized STD testing clinics
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Increasing preference for swab tests for STD testing for their non-invasive nature
  • 5.2.2. Product Type: Need for high-throughput instruments for high-volume testing environments
  • 5.2.3. Test Settings: Preference for POC tests for their unmatched convenience and speed
  • 5.2.4. Indication: Rising occurrence of chlamydia and need for sophisticated testing technologies
  • 5.2.5. End-user: Expanding usage of STD testing at diagnostic centers for quick turnaround time
• 5.3. Market Trend Analysis
  • 5.3.1. Growing popularity of at-home STD testing kits, coupled with a strong foothold of major companies across the Americas region
  • 5.3.2. Expanding government awareness initiatives against STDs due to the prevalence of STDs across the APAC region
  • 5.3.3. Stringent regulatory frameworks for diagnostic solutions and innovative product offerings for facilitating accessible STD testing across the EMEA region
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Bargaining Power of Customers
  • 5.5.4. Bargaining Power of Suppliers
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework Analysis

6. STD Testing Market, by Type

• 6.1. Introduction
• 6.2. Blood Tests
• 6.3. Lumbar Puncture
• 6.4. Swab Tests
• 6.5. Urine Tests

7. STD Testing Market, by Product Type

• 7.1. Introduction
• 7.2. Instruments
• 7.3. Reagents & Kits

8. STD Testing Market, by Test Settings

• 8.1. Introduction
• 8.2. Laboratory
• 8.3. Point of Care

9. STD Testing Market, by Indication

• 9.1. Introduction
• 9.2. Chlamydia
• 9.3. Genital Herpes
• 9.4. Gonorrhea
• 9.5. Hepatitis B
• 9.6. HIV/AIDS
• 9.7. Human Papillomavirus
• 9.8. Syphilis

10. STD Testing Market, by End-user

• 10.1. Introduction
• 10.2. Diagnostic Centers
• 10.3. Hospitals & Clinics

11. Americas STD Testing Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific STD Testing Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa STD Testing Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Strategic Alliance Advances Self-Test Solutions for Sexually Transmitted Diseases
  • 14.3.2. imaware Expands its Portfolio through binx health's Consumer Division Purchase
  • 14.3.3. FDA Approves Advanced At-home Chlamydia and Gonorrhea Test
  • 14.3.4. British Startup Launches Tampon That Offers STI Screening
  • 14.3.5. iHealth Launches Home Collection Kit for STD Testing
  • 14.3.6. Aptitude Medical Systems' Innovative Approach to Combat Sexually Transmitted Infections (STIs)
  • 14.3.7. LifeCell International Revolutionizes STD and HPV Screening with At-Home Test Kits
  • 14.3.8. Breakthrough 20-Minute Test for Gonorrhea and Chlamydia by Linear Diagnostics
  • 14.3.9. US BioTek's Innovative At-Home Testing Solutions
  • 14.3.10. Visby Medical Achieves FDA Clearance for Advanced Sexual Health Diagnostic Tool
  • 14.3.11. Mylab Launches a Range of Rapid Tests for STDs
  • 14.3.12. Strategic Partnership between Maternova and MedMira Enhances Global Access to Rapid Diagnostic Tests for Infectious Diseases
  • 14.3.13. Innovative Partnership Tackles STI Spike Among Gen Z with At-Home Testing Solutions
  • 14.3.14. Meridian Bioscience Joins Forces with SD Biosensor and SJL Partners

15. Competitive Portfolio

• 15.1. Key Company Profiles
• 15.2. Key Product Portfolio